Dr. Van Cott is an invited expert participant at the College of American Pathologists consensus conferences in coagulation. She is a strong advocate of coagulation laboratory guidelines and standards.
Elizabeth Van Cott, MD is Director of the Coagulation Laboratory and Medical Director of the Core Laboratory at Massachusetts General Hospital and Associate Professor of Pathology at Harvard Medical School. She is President of the North American Specialized Coagulation Laboratory Association (NASCOLA). She is an advisor for the Area Committee on Hematology for the Clinical and Laboratory Standards Institute (CLSI), and is actively involved in writing coagulation laboratory guidelines for CLSI. She is an inaugural member of the new Standards Committee of the College of American Pathologists (CAP), and she recently completed a six-year term on the CAP Coagulation Resource Committee. She has over 100 publications in the field of coagulation. She is associate editor, section editor, or editorial board member for multiple journals. She serves on the steering committee for the inaugural THSNA (Thrombosis and Hemostasis Societies of North America) summits in 2012 and 2014, and serves on the inaugural THSNA Board of Directors. She was an invited expert participant at the two most recent CAP consensus conferences in coagulation which generated consensus guidelines on Laboratory Monitoring of Anticoagulant Therapy as well as Thrombophilia.
Research interests include:
Clinically-oriented studies in thrombosis and hemostasis
Research is focused on coagulation, in particular, diagnostic coagulation testing and heparin-induced thrombocytopenia (HIT), including new anticoagulants for the treatment of HIT